| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Alnylam Pharmaceuticals, Inc. (ALNY) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 93 sells. ALNY is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 79.1K | $22.00M | - | |
| CFO | 58.4K | $16.24M | - | |
| VP | 29.8K | $8.28M | - | |
| VP | 23.7K | $6.59M | - | |
| Dir | 23.2K | $6.45M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 2025 | Poulton Jeffrey V.45 | EVP, Chief Financial Officer | Sell | 3,821 | $452.05 | $1,727,283.60 | -0.6% | -13.7% | - | |
| Oct 2, 2025 | Greenstreet Yvonne49 | Chief Executive Officer | Sell | 8,924 | $452.05 | $4,034,084.66 | -1.1% | -13.7% | - | |
| Sep 9, 2025 | Reitan Colleen F69 | Director | Sale+OE | 18,000 | $467.60 | $8,416,729.64 | -12.2% | -10.8% | - | |
| Aug 29, 2025 | Tanguler Tolga57 | EVP, Chief Commercial Officer | Sell | 3,474 | $448.37 | $1,557,649.44 | -2.1% | +1.1% | - | |
| Aug 19, 2025 | Garg Pushkal50 | EVP Chief R&D | Sell | 2,851 | $455.89 | $1,299,745.87 | -0.9% | +0.5% | - | |
| Aug 18, 2025 | Bonney Michael W | Director | Sale+OE | 11,250 | $450.00 | $5,062,500.00 | -40.1% | +0.8% | - | |
| Aug 18, 2025 | Tanguler Tolga57 | EVP, Chief Commercial Officer | Sell | 1,396 | $453.27 | $632,758.71 | -0.6% | +0.8% | - | |
| Aug 18, 2025 | Poulton Jeffrey V.45 | EVP, Chief Financial Officer | Sell | 2,274 | $453.27 | $1,030,727.12 | -0.6% | +0.8% | - | |
| Aug 18, 2025 | Greenstreet Yvonne49 | Chief Executive Officer | Sell | 6,979 | $453.27 | $3,163,345.74 | -1.4% | +0.8% | - | |
| Aug 18, 2025 | Fitzgerald Kevin Joseph | CSO &EVP, Head Of Research | Sell | 1,396 | $453.27 | $632,758.71 | -0.7% | +0.8% | - |